Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Person › Details

Arthur Lahr (Kiadis Pharma N.V. (Euronext: KDS))

Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)

	Organisation	Kiadis Pharma N.V. (Euronext: KDS)
	Group	Kiadis (Group)
	Former/major organisation	Crucell N.V. (Euronext: CRXL, Nasdaq: CRXL)
	Group	Johnson & Johnson (JnJ) (Group)
	Product	ATIR™ (Kiadis)
	Source	Kiadis Pharma N.V.. (6/13/17). "Press Release: Kiadis Pharma Raises €5 Million in Private Placement with Institutional Investors [Not for US, AU, CA, JP, ZA or any other jurisdiction where unlawful]". Amsterdam.

Record changed: 2020-11-02

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Arthur Lahr

[1] Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam....
[2] Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam....
[3] Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam....
[4] Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam....
[5] Kiadis Pharma N.V.. (10/17/19). "Press Release: Kiadis Pharma Provides Regulatory Update on ATIR101". Amsterdam....
[6] Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam....
[7] Kiadis Pharma N.V.. (6/6/19). "Press Release: Kiadis Pharma Completes Acquisition of CytoSen Therapeutics, Inc.". Amsterdam....
[8] Kiadis Pharma N.V.. (5/29/19). "Press Release: Kiadis Pharma’s Extraordinary General Meeting of Shareholders Approves CytoSen Acquisition". Amsterdam....
[9] Kiadis Pharma N.V.. (4/17/19). "Press Release: Kiadis to Acquire CytoSen Therapeutics, Inc.". Amsterdam....
[10] Kiadis Pharma N.V.. (3/5/19). "Press Release: Kiadis Pharma Strengthens Management Team". Amsterdam....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]